| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.33 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.099 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.091 | 0.06 |